HOME >> BIOLOGY >> NEWS
Translating form into function

In the last 40 years, scientists have perfected ways to determine the knot-like structure of enzymes, but theyve been stumped trying to translate the structure into an understanding of function what the enzyme actually does in the body. This puzzle has hindered drug discovery, since many of the most successful drugs work by blocking enzyme action. Now, in an expedited article in NATURE, researchers show that a solution to the puzzle is finally in sight.

A team co-led by UCSFs Brian Shoichet, Steven Almo of the Albert Einstein College of Medicine, and Frank Raushel of Texas A&M describes the first success decrypting an enzymes function from its structure. If their new strategy works with other enzymes, it should become a potent tool to determine how key enzymes work in the body. And since enzyme action is crucial to disease, the technique opens an efficient route to drug discovery, Shoichet say.

Schoichet a professor of pharmaceutical chemistry and an investigator in the California Institute for Quantitative Biomedical Research, or QB3, based at UCSF.

The teams success came by modifying a technique called molecular docking, a computer-aided modeling strategy used to search for potential drugs. Docking works by allowing researchers to first determine the atom-by-atom structure of an enzyme and then screen many thousands of molecules for one that fits into the empty active site of the enzyme.

Shoichet calls this a search for the missing piece of a jigsaw puzzle. A molecule that fits the enzymes active site will block its activity just what many promising drugs do.

The strategy works well for one kind of drug discovery -- finding molecules to fit in the active site and physically block enzyme action. But the research team sought to divine from an enzymes structure just what natural molecule triggers the enzyme into action -- fitting into the active site and enabling the enzyme to act as a catalyst. This was a search for the so-called substra
'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
1-Jul-2007


Page: 1 2

Related biology news :

1. UCLA scientists produce functioning neurons from human embryonic stem cells
2. Cardiac patches stimulate regeneration, improve function after heart attack
3. Accident-prone? Scientists link brain function to knee injuries
4. Researchers use new approach to predict protein function
5. Engineered blood vessels function like native tissue
6. Research finds that circadian rhythms dominate all life functions
7. Mucosal-surface immune function discoveries could boost vaccine research
8. University of Washington researchers play leading role in major study of human genome function
9. What causes Alzheimers? Researchers tie beta-amyloids to brain dysfunction
10. Gene therapy delivery of nerve growth factors reverses erectile dysfunction in animal model
11. UGA study reveals function of ubiquitous yet poorly understood microorganisms

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Translating form into function

(Date:6/17/2013)... by fungi, bacteria, and algae, is a common component ... used in the medical field it,s approved by ... fluids and used during surgery as a substance that ... other drugs. , Now Profs. Ehud Gazit and Daniel ... and Biotechnology and the Sagol School of Neuroscience, along ...
(Date:6/17/2013)... will be the topics under discussion during the ... the third consecutive year, this will be a ... experiences among members of Academy, Business, Educators, Entrepreneurs, ... speakers: Elisa Martn Garijo (IBM South Europe), Chris ... Mary O,Donovan (Hovione), among others. E3 Forum - ...
(Date:6/17/2013)... available in French . ... older mice with Alzheimer,s disease can be reversed with treatment. ... Hospital - The Neuro, at McGill University and at Universit ... receptor in the brain of mice with advanced Alzheimer,s disease ... the Journal of Neuroinflammation in May, also suggest ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2'E3 Forum -- Education, Employment & Entrepreneurship on a Global context' 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2
(Date:6/14/2013)... 2013  Royalty Pharma notes today,s announcement by Elan Corporation, ... explore a sale of the Company. Royalty Pharma believes it ... certainty that a deal will ever be reached. Royalty Pharma calls ... AGAINST all four resolutions up for consideration at Elan,s EGM ... formal offer for Elan. In response to the announcement ...
(Date:6/14/2013)... June 14, 2013 The OpenClinica ... Hotel, Boston, MA this year with Formedix CEO, Mark ... valuable sessions, offering attendees a deeper insight into the ... with partners, such as Formedix to develop innovative solutions. ... to learn all about OpenClinica, hear real-life case studies ...
(Date:6/14/2013)... June 14, 2013 The Pittcon Exposition ... 2014, which will be held March 3-6, 2014, at ... Chicago, Illinois. The cost per booth after July 15, ... the first round of booth assignments should have their ... placements will begin August 2013. , Pittcon attracts a ...
(Date:6/14/2013)...  The Pittsburgh Life Sciences Greenhouse (PLSG) today announced ... were necessitated by delays in portfolio company exits caused ... of state funding. PLSG President and CEO, ... only pure life sciences investment firm, the actions taken ... of Directors, were necessary to protect the future of ...
Breaking Biology Technology:Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 2Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 3Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 4Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 5Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 6Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 7Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 8Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 9Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 10Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty 11Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 2Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 3Pittcon 2014 Now Accepting Booth Space Reservations 2Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding 2
Cached News: